A Streamlined Approach for Biotherapeutic Characterization This presentation will discuss a streamlined solution for collecting and processing data for routine intact mass and peptide workflows.
The Lipidyzer™ Platform: A Revolutionary Tool for Understanding the Role of Lipids in Disease Join us to learn about the key challenges in lipid analysis and how the Lipidyzer platform can help you overcome them.
A New Proteomics Workflow for the Identification of PTMs (Post Translational Modifications) Quantitative proteomics is an essential tool in molecular biology and biomedical sciences. SILAC is a commonly used workflow in which proteins are labelled with stable isotopes, digested into peptides and separated by chromatography for detection in a mass spectrometer.
Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer Sarah Hayes, University of Sydney, speaking at Diagnostics & Biomarkers 2015.
Genome-Scale Protein Expression Analysis of Individual Solid Tumors Metodi Metodiev, University of Essex, speaking at Diagnostics and Biomarkers 2015.
New Metabolomics Biomarker for Heart Failure Philipp Schatz, Metanomics Health GmbH, speaking at Diagnostics & Biomarkers 2015.
Creating a Clinical Diagnostic Test from Discovery Through Launch with Mass Spectrometry Daniel Chelsky, Caprion Proteomics Inc, speaking at Diagnostics & Biomarkers 2015.
LC-High Resolution-MS in Clinical Labs: A Step Forward for TDM and Metabotyping Bertrand Rochat, Centre Hospitalier Universitaire Vaudois, speaking at Clinical Applications of Mass Spectrometry.
Contributions of Mass Spectrometry in the Diagnosis and Management of Hypothalamic–pituitary–adrenal Axis Disorders Gregori Casals, Hospital Clínic Barcelona, speaking at Clinical Applications of Mass Spectrometry.
History and Development of High Resolution Mass Spectrometry for Infectious Disease Diagnostics Haroun Shah, Public Health England, speaking at Clinical Applications of Mass Spectrometry.